UNSPSC 51301801: Butenafine

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 91Y494NL0X. European Medicines Agency schedules Butenafine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06012MIG. Butenafine generally arises in the molecular formula C23H27N.

UNSPSC 51301801 Butenafine, a Commodity code, shows a material mismatch between its nominal scope and recent state and local purchasing activity. The code nominally covers butenafine, an antifungal active pharmaceutical ingredient, yet the two most recent opportunities posted under this code involve liquid aluminum sulfate (alum) for wastewater treatment and medical first-aid supplies (bandages, antiseptics, pain relievers, and emergency blankets) — neither of which relates to butenafine. The City of Austin issued IFB 2200 CSH1061 on July 27, 2026, seeking unpackaged liquid aluminum sulfate at 47%–49% concentration for phosphorus removal at its wastewater treatment facility, with bids due August 25, 2026. The City of Tampa Fire Rescue Department posted ITB 25-P-00157 on April 24, 2026, for a range of first-aid supplies including antiseptic sprays, hydrogen peroxide, aspirin, bandages, first-aid kits, and emergency blankets, with an estimated annual procurement budget of $100,000. These two solicitations indicate that the code is currently capturing purchases unrelated to pharmaceutical ingredients or topical antifungal products.

Geographic activity is limited to Texas (Austin) and Florida (Tampa) based on recent opportunities; no other jurisdictions have posted under this code recently. The Austin opportunity is a straightforward materials procurement with local and small-business preference discounts (5% for local businesses and small-business status in the first $500,000 band), while the Tampa opportunity emphasizes set-asides for Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises with additional bid discounts capped at $10,000 and $20,000 respectively. The code shows minimal recent activity and the opportunities present do not align with butenafine procurement — this signals either misclassification by the issuing bodies or that the code is not actively used for its nominal scope in state and local procurement.